NO151285C - Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater

Info

Publication number
NO151285C
NO151285C NO791604A NO791604A NO151285C NO 151285 C NO151285 C NO 151285C NO 791604 A NO791604 A NO 791604A NO 791604 A NO791604 A NO 791604A NO 151285 C NO151285 C NO 151285C
Authority
NO
Norway
Prior art keywords
glycerold
derivatives
alkyl
preparation
therapeutically active
Prior art date
Application number
NO791604A
Other languages
English (en)
Other versions
NO791604L (no
NO151285B (no
Inventor
Allen Richard Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO791604L publication Critical patent/NO791604L/no
Publication of NO151285B publication Critical patent/NO151285B/no
Publication of NO151285C publication Critical patent/NO151285C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO791604A 1978-05-15 1979-05-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater NO151285C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants

Publications (3)

Publication Number Publication Date
NO791604L NO791604L (no) 1979-11-16
NO151285B NO151285B (no) 1984-12-03
NO151285C true NO151285C (no) 1985-03-13

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
NO791604A NO151285C (no) 1978-05-15 1979-05-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater

Country Status (38)

Country Link
US (1) US4173641A (no)
JP (2) JPS5924974B2 (no)
AR (1) AR221724A1 (no)
AT (1) AT372678B (no)
AU (1) AU513771B2 (no)
BE (1) BE876229A (no)
CA (1) CA1105935A (no)
CH (1) CH639939A5 (no)
DD (1) DD144540A5 (no)
DE (1) DE2919514C2 (no)
DK (1) DK149946C (no)
EG (1) EG15252A (no)
ES (1) ES480565A1 (no)
FI (1) FI69450C (no)
FR (1) FR2426039A1 (no)
GB (1) GB2021580B (no)
GR (1) GR72419B (no)
GT (1) GT197957869A (no)
HK (1) HK13584A (no)
HU (1) HU180283B (no)
IE (1) IE48229B1 (no)
IL (1) IL57268A (no)
IN (1) IN150574B (no)
IT (1) IT1115217B (no)
KE (1) KE3354A (no)
LU (1) LU81253A1 (no)
MY (1) MY8500096A (no)
NL (1) NL175524C (no)
NO (1) NO151285C (no)
NZ (1) NZ190444A (no)
PH (1) PH15256A (no)
PL (1) PL123910B1 (no)
PT (1) PT69607A (no)
SE (1) SE429966B (no)
SG (1) SG65483G (no)
SU (1) SU1122220A3 (no)
YU (1) YU41156B (no)
ZA (1) ZA792306B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
US20110200582A1 (en) * 2009-12-23 2011-08-18 Novartis Ag Lipids, lipid compositions, and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
YU109479A (en) 1983-02-28
FR2426039A1 (fr) 1979-12-14
JPS6139301B2 (no) 1986-09-03
FI69450B (fi) 1985-10-31
GB2021580B (en) 1982-09-08
NL7903769A (nl) 1979-11-19
ATA356179A (de) 1983-03-15
SE429966B (sv) 1983-10-10
GB2021580A (en) 1979-12-05
DK149946B (da) 1986-11-03
PL215573A1 (no) 1980-07-01
NO791604L (no) 1979-11-16
KE3354A (en) 1983-12-16
GT197957869A (es) 1980-11-04
FI791531A (fi) 1979-11-16
US4173641A (en) 1979-11-06
IL57268A (en) 1982-05-31
AU513771B2 (en) 1980-12-18
ZA792306B (en) 1980-05-28
CA1105935A (en) 1981-07-28
YU41156B (en) 1986-12-31
IT1115217B (it) 1986-02-03
PT69607A (en) 1979-06-01
JPS58131947A (ja) 1983-08-06
NZ190444A (en) 1981-05-29
BE876229A (fr) 1979-11-14
DK149946C (da) 1987-06-15
PL123910B1 (en) 1982-12-31
DD144540A5 (de) 1980-10-22
PH15256A (en) 1982-11-02
IT7922664A0 (it) 1979-05-14
IE48229B1 (en) 1984-11-14
NL175524C (nl) 1984-11-16
SG65483G (en) 1984-07-27
FI69450C (fi) 1986-02-10
LU81253A1 (fr) 1979-12-07
JPS5924974B2 (ja) 1984-06-13
IN150574B (no) 1982-11-13
MY8500096A (en) 1985-12-31
FR2426039B1 (no) 1983-12-16
DE2919514C2 (de) 1982-06-03
ES480565A1 (es) 1980-08-16
IE790938L (en) 1979-11-15
HK13584A (en) 1984-02-24
JPS55378A (en) 1980-01-05
GR72419B (no) 1983-11-03
DK102479A (da) 1979-11-16
IL57268A0 (en) 1979-09-30
SE7904216L (sv) 1979-11-16
AR221724A1 (es) 1981-03-13
AU4701679A (en) 1979-11-22
NO151285B (no) 1984-12-03
DE2919514A1 (de) 1979-11-22
CH639939A5 (fr) 1983-12-15
HU180283B (en) 1983-02-28
EG15252A (en) 1986-09-30
SU1122220A3 (ru) 1984-10-30
AT372678B (de) 1983-11-10

Similar Documents

Publication Publication Date Title
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO792829L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer